Alpha 2.0
Login Register
» Articles » PMID: 6789857

Localization of Human Tumour Xenografts After I.v. Administration of Radiolabeled Monoclonal Antibodies

Overview
Journal Br J Cancer
Specialty Oncology
Date 1981 Jul 1
PMID 6789857
Citations 32
Authors
V Moshakis
R A McIlhinney
D Raghavan
A M Neville
Affiliations
Soon will be listed here.
Abstract

A mouse monoclonal antibody (LICR-LON/HT13) has been developed to a cell-surface antigen carried on a human germ-cell tumour xenograft (HX39). After radioiodination, the antibody localized in vivo preferentially in xenografted tumours as opposed to normal mouse tissue, whereas tumor uptake did not occur with normal mouse IgG or nonspecific monoclonal IgG. This selective localization could be abolished by simultaneous injection of an excess of the unlabelled LICR-LON/HT13. The kinetics of and factors influencing localization have been examined. Tumour weight was important in that the smaller the tumour the better the localization. LICR-LON/HT13 was found to localize also in other xenografted germ-cell tumours, but not in non-germ-cell tumour xenografts. Thus monoclonal antibodies are capable of selective in vivo localization of human tumours in an animal model, and their clinical value should now be assessed.

Citing Articles

Evaluation of Near-infrared Fluorescence-conjugated Peptides for Visualization of Human Epidermal Receptor 2-overexpressed Gastric Cancer.

Jeong K, Kong S, Bae S, Park C, Berlth F, Shin J J Gastric Cancer. 2021; 21(2):191-202.

PMID: 34234980 PMC: 8255305. DOI: 10.5230/jgc.2021.21.e18.

A Revisit to the Pretargeting Concept-A Target Conversion.

Liu G Front Pharmacol. 2019; 9:1476.

PMID: 30618765 PMC: 6304396. DOI: 10.3389/fphar.2018.01476.

Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling.

Pruszynski M, Koumarianou E, Vaidyanathan G, Revets H, Devoogdt N, Lahoutte T J Nucl Med. 2014; 55(4):650-6.

PMID: 24578241 PMC: 4157601. DOI: 10.2967/jnumed.113.127100.

Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.

Schoffelen R, van der Graaf W, Sharkey R, Franssen G, McBride W, Chang C EJNMMI Res. 2012; 2:5.

PMID: 22284761 PMC: 3298693. DOI: 10.1186/2191-219X-2-5.

90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.

Liu G, Dou S, Liu Y, Wang Y, Rusckowski M, Hnatowich D Bioconjug Chem. 2011; 22(12):2539-45.

PMID: 21985267 PMC: 3244554. DOI: 10.1021/bc200366t.

References
1.
Primus F, Wang R, Goldenberg D, Hansen H . Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen. Cancer Res. 1973; 33(11):2977-82. View
2.
Mach J, Carrel S, Merenda C, Sordat B, Cerottini J . In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature. 1974; 248(5450):704-6. DOI: 10.1038/248704a0. View
3.
Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View
4.
Galfre G, Howe S, Milstein C, Butcher G, Howard J . Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature. 1977; 266(5602):550-2. DOI: 10.1038/266550a0. View
5.
Williams A, Galfre G, Milstein C . Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell. 1977; 12(3):663-73. DOI: 10.1016/0092-8674(77)90266-5. View